Journals / Van Tıp Dergisi / 2013 / Cilt: 20 - Sayı: 1

In migraine headache: What should we do?

Migren baş ağrısında: Ne yapmalıyız?

Pages
40–47
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These new treatment approaches not only trigger new hopes for patients but also reduce serious socio-economic effects that are induced by this disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Migraine is a primary headache disorder that affects 10% of the population including mostly young and middle-aged individuals and reduces quality of life and labor force.
📊
Key Findings & Data:Although many treatment options are put forward, treatment of many patients still is not satisfactory.
💡
Conclusion & Impact:These new treatment approaches not only trigger new hopes for patients but also reduce serious socio-economic effects that are induced by this disease.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Migraine is a primary headache disorder that affects 10% of the population including mostly young and middle-aged individuals and reduces quality of life and labor force. Although many treatment options are put forward, treatment of many patients still is not satisfactory. Better understanding of the disease pathogenesis will cause more effective treatment in the future. These new treatment approaches not only trigger new hopes for patients but also reduce serious socio-economic effects that are induced by this disease.

Özet

Migren; insanların hayat kalitesi ve iş gücünü azaltan, çoğunlukla genç ve orta yaşlı bireyler olmak üzere popülasyonun %10’nunu etkileyen primer baş ağrısı bozukluğudur. Ortaya konulan pek çok tedavi seçeneklerine rağmen bugün halen pek çok hasta için tedavi memnun edici değildir. İlerleyen yıllarda hastalığın patogenezinin daha iyi anlaşılmasıyla daha etkili tedavilerin ortaya konulması kaçınılmazdır. Bu yeni tedavi seçenekleri sadece hastalarda yeni ümitlere neden olmayacak, bunun yanında hastalığın ciddi sosyoekonomik etkilerini de azaltacaktır.

🔖

Cite This Article

MİLANLIOĞLU, A., TOMBUL, T. (2013). In migraine headache: What should we do?. Van Tıp Dergisi, Cilt: 20 - Sayı: 1, 40–47. https://ajindex.com/articles/334128

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (19)

  1. Goadsby PJ. Current concepts of the pathophysiology of migraine. Neurol Clin 1997
  2. 15(1):27-42. 2.Saper JR. Diagnosis and symptomatic treatment of migraine. Headache 1997
  3. 37(1):1-14. 3.Dowson AJ. Sorularınıza Yanıtlar Migren ve Diğer Baş Ağrıları. 1. Baskı, 2003
  4. Vural O. Baş Ağrıları Özel Sayısı. Türkiye Klinikleri Nöroloji 2003
  5. Siva A. Baş, Boyun, Bel Ağrıları Sempozyum Dizisi No: 30. 2002
  6. Rotrock DA, King W, Rotrock J. An analysis of migrainetriggers in a clinical-based population. Headache 2010
  7. 50(8):1366-1370. 7.Bradley W, Daroff R, Fenichel G, Jankovic J. Neurology in Clinical Practice. İstanbul: Veri Medikal Yayıncılık 2008
  8. Mathew NT. Akut Migren Ataklarının Tedavisi Baş Ağrısı El kitabı. Phidalphia: Lippincott Williams and Wilkins 2005
  9. Fuller GN, Guiloff RJ. Propranolol in acute migraine: a controlled study. Cephalalgia 1990
  10. 10(5):229-233. 10.Leniger T, Pageler L, Stude P, Diener HC, Limmroth V. Comparison of intravenous valproate with intravenous lysine- acetylsalicylic acid in acute migraine attacks. Headache 2005
  11. 45(1):42-46. 11.Rosen N, Silberstein S, Abbas MA. Effect of lidocaine infusion in the treatment of refractory cronic daily headache-a retrospective study. Neurology 2006
  12. Silberstein SD. Appropriate use of abortive medication in the headache treatment. Pain Mgt 1991
  13. Sun-Edelstein C, Mauskop A. Role of magnesium in the pathogenesis and treatment. Expert Rev Neurother 2009
  14. 9(3):369-379. 14.Bigal ME, Bordini CA, Tepper SJ, Speciali JG. Intravenous magnesium sulphate in the acute treatment of migraine without aura and migraine with aura. A randomized, double- blind, placebo-controlled study. Cephalalgia 2002
  15. 22(5):345-353. 15.Krusz JC, Belanger J. Propofol-a highly effective treatment for acute headaches. Cephalalgia 1999
  16. Diamond S, Phillips SB, Berstein JE. Intra- nasal Civamide for acute treatment of migraine headache. Headache 1999
  17. Goldstein DJ, Offen WW, Klein EG, Phebus LA. Lanepitant, an NK-1 antagonist, in migraine prophylaxis. Cephalalgia 1999
  18. Brändli P, Löffler BM, Breu V, Osterwalder R, Maire JP, Clozel M. Role of endothelin in mediating neurogenic plasma extravasation in rat dura mater. Pain 1996
  19. 64(2):315-322. 19.Diener HC, Matias-Guiu J, Hartung E, Pfaffenrath V, Ludin HP, Nappi G, et al. Efficacy and tolerability in migraine prophylaxis of flunarizine in reduced doses: a comparison with propranolol 160